You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-196

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Solid Tumor Trial in Durham (HS-196)

Suspended
  • Solid Tumor
  • Durham, North Carolina
    Duke University Medical Center
Dec 19, 2022

Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
May 21, 2021

Healthy Participants Trial in Tempe (ACP-196, Itraconazole)

Completed
  • Healthy Participants
  • Tempe, Arizona
    Celerion
May 20, 2021

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

Hepatic Insufficiency Trial in Miami, Orlando, Knoxville (ACP-196)

Completed
  • Hepatic Insufficiency
  • Miami, Florida
  • +2 more
Apr 28, 2021

Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)

Active, not recruiting
Has Results
  • Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
  • Los Angeles, California
  • +6 more
Dec 1, 2022

Eosinophils, Asthma Trial in Worldwide (reslizumab)

Terminated
Has Results
  • Eosinophils, Asthma
  • Birmingham, Alabama
  • +133 more
Dec 9, 2022

Uveal Melanoma Trial in Worldwide (LXS196, LXS196 and HDM201)

Terminated
  • Uveal Melanoma
  • New York, New York
  • +5 more
Sep 27, 2022

System of Autism Spectrum Disorder From an Existing Big Cohort

Completed
  • Autism Spectrum Disorder
  • Psychiatric diagnosis
  • ASD diagnosis
  • Taipei, Taiwan
    National Taiwan Univeristy Hospital
Sep 23, 2022

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
Has Results
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

Active, not recruiting
Has Results
  • Waldenström Macroglobulinemia (WM)
  • Acalabrutinib (ACP-196)
  • Santa Barbara, California
  • +37 more
Mar 17, 2022

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Relative Energy Deficiency in Sport Trial in Istanbul (Nutrition education)

Completed
  • Relative Energy Deficiency in Sport
  • Nutrition education
  • Istanbul, Sarıyer, Turkey
    Baltalimanı Research and Training Hospital
Nov 2, 2023

Small Cell Lung Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +3 more
  • Fort Myers, Florida
  • +113 more
Nov 30, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
Nov 4, 2022

Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

Not yet recruiting
  • Alpha1-Antitrypsin Deficiency
  • Fazirsiran Injection
  • Placebo
  • (no location specified)
Feb 2, 2023

COVID-19 Trial in Beijing (BRII-196, Placebo)

Completed
  • COVID-19
  • Beijing, Beijing, China
    Investigative Site
Mar 1, 2022

Schizophrenia Trial in Worldwide (DSP-5423P Placebo, DSP-5423P 40mg, DSP-5423P 80mg)

Completed
Has Results
  • Schizophrenia
  • DSP-5423P Placebo
  • +4 more
  • Beijing, Etc., China
  • +7 more
Apr 9, 2022

Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

Completed
Has Results
  • Migraine Headache
  • DFN-15 Active
  • DFN-15 Placebo
  • Birmingham, Alabama
  • +44 more
Dec 15, 2022

Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD) Trial in Canada, United Kingdom, United States (Ferumoxytol, Iron

Completed
Has Results
  • Iron Deficiency Anemia Treatment
  • Chronic Kidney Disease(CKD)
  • Pine Bluff, Arkansas
  • +42 more
Mar 31, 2022

Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2023

COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)

Withdrawn
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Hong Kong, China
    Investigative Site 1
Mar 1, 2022